EUDA Health Holdings Ltd
corporate_fare Company Profile
EUDA Health Holdings Ltd (NASDAQ:EUDA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for EUDA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for EUDA spans 6-K, F-3, 20-F, 424B5.
Recent high-impact activity:
- EUDA Health Proposes Dual-Class Structure Giving Tan Meng Dong 89.5% Voting Control
- EUDA Health Reports H1 2026 Loss, Going Concern Warning, and $7.6M Crypto Asset Acquisition
- EUDA Health Enters Tri-Party MOU for Next-Generation iPSC and NK-TCR Cell Therapies
- EUDA Health Inks Tri-Party MOU to Develop Next-Gen iPSC and NK-TCR Cell Therapies
- EUDA Health Terminates $10M At-The-Market Offering, Removing Dilution Overhang
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 6,429 shares in EUDA as of the October 30, 2026 settlement, a 297.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 58.5% of EUDA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for EUDA, detected from its recent SEC filings · based on capital-structure filings through 2026-07-22.
ATM Offering Terminated · Potential Dilution Removed
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →
Insider Transactions
EUDA files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.